Matthew Harju
About Matthew Harju
Matthew Harju serves as the Director of National Accounts at Mirum Pharmaceuticals, Inc. He specializes in ultra orphan disease states and has extensive experience in hospital sales strategies and reimbursement strategies.
Current Role at Mirum Pharmaceuticals
Matthew Harju serves as the Director of National Accounts at Mirum Pharmaceuticals, Inc., a position he has held since 2022. In this role, he focuses on developing and managing national account strategies to enhance the company's presence in the market. His responsibilities include engaging with key stakeholders and ensuring effective communication between the company and its partners.
Previous Experience in Pharmaceuticals
Before joining Mirum Pharmaceuticals, Matthew Harju held various positions in the pharmaceutical industry. He worked as an Associate Director and Regional Account Manager at AveXis, Inc. from 2018 to 2022, and as a Senior Rare Disease Manager at Aegerion Therapeutics from 2012 to 2015. His experience includes a significant tenure at Actelion Pharmaceuticals as a Territory Manager from 2006 to 2012, where he focused on the Greater NYC area.
Expertise in Rare Diseases and Therapies
Matthew Harju specializes in ultra orphan disease states, particularly in Gene Replacement and Enzyme Replacement Therapies. His expertise extends to developing reimbursement strategies in the Buy and Bill arena, where he collaborates with hospital teams, including C-Suite and Revenue Cycle Teams, to ensure effective treatment access for patients.
Educational Background
Matthew Harju studied at Ramapo College, where he earned a Bachelor of Arts in Business Administration with a focus on Economics. His academic journey spanned from 1994 to 1999, providing him with a solid foundation in business principles that he applies in his professional career.
Sales and Account Management Experience
Matthew Harju has extensive experience in sales and account management, having worked in various roles across multiple companies. His career includes positions at GlaxoSmithKline as an Executive Pharmaceutical Sales Representative and at BioMarin Pharmaceutical Inc. as an Institutional Account Manager. He has also worked in the financial sector as a Loan Officer at American Eagle Mortgage.